ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Nymox Pharmaceutical Corp

Nymox Pharmaceutical Corp (NYMX)

0.20
0.00
(0.00%)
Closed November 27 4:00PM
0.20
0.00
( 0.00% )
Pre Market: 7:00PM

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0009k0000
Operating Income -2.8M-5.07M-1.78M-1.48M1.68M-1.39M-1.1M-1.01M
Pre Tax Income -2.81M-5.09M1.34M-1.49M-1.34M-1.39M-1.11M-1.04M
Net Income -2.81M-5.09M1.34M-1.49M-1.34M-1.39M-1.11M-1.04M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -2.8M-5.07M1.33M-1.48M-1.32M-1.39M-1.1M-1.01M
EBITDA -2.79M-5.07M-1.78M-1.48M1.69M-1.38M-987k-973k
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 283k224k299k116k5k000
Operating Income -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.65M-8.79M
Pre Tax Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Net Income -13.11M-13.43M-10.59M-13.16M-11.74M-12.54M-6.58M-8.84M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.267-0.238-0.164-0.185-0.151-0.147-0.073-0.095
EBIT -12.87M-13.24M-10.64M-13.33M-11.72M-12.5M-6.54M-8.79M
EBITDA -12.87M-13.23M-10.64M-13.33M-11.71M-12.49M-6.64M-8.79M

Your Recent History

Delayed Upgrade Clock